Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs. 2009 Jun 18; 69(9):1205-16.

View in: PubMed

subject areas

Adrenal Cortex Hormones
Adrenergic beta-Agonists
Adult
Aged
Albuterol
Area Under Curve
Bronchodilator Agents
Drug Therapy, Combination
Dyspnea
Ethanolamines
Female
Forced Expiratory Volume
Formoterol Fumarate
Humans
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive
Quality of Life
Scopolamine Derivatives
Spirometry
Tiotropium Bromide

authors with profiles

NICOLA HANANIA